Evaxion Presents Positive and Validating Immune Data From Ongoing Phase 2 Trial With AI-Designed Evx-01 Vaccine at the Asco Annual Meeting 2024
Evaxion在2024年ASCO年會上展示了AI設計的Evx-01疫苗的積極有效的免疫數據
Evaxion Presents Positive and Validating Immune Data From Ongoing Phase 2 Trial With AI-Designed Evx-01 Vaccine at the Asco Annual Meeting 2024
Evaxion在2024年ASCO年會上展示了AI設計的Evx-01疫苗的積極有效的免疫數據
譯文內容由第三人軟體翻譯。